200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 85872-53-3

85872-53-3

85872-53-3 | 8-Phenyl-1,3-dipropyl-1H-purine-2,6(3H,7H);-dione

CAS No: 85872-53-3 Catalog No: AG004NI6 MDL No:

Product Description

Catalog Number:
AG004NI6
Chemical Name:
8-Phenyl-1,3-dipropyl-1H-purine-2,6(3H,7H);-dione
CAS Number:
85872-53-3
Molecular Formula:
C17H20N4O2
Molecular Weight:
312.3663
IUPAC Name:
8-phenyl-1,3-dipropyl-7H-purine-2,6-dione
InChI:
InChI=1S/C17H20N4O2/c1-3-10-20-15-13(16(22)21(11-4-2)17(20)23)18-14(19-15)12-8-6-5-7-9-12/h5-9H,3-4,10-11H2,1-2H3,(H,18,19)
InChI Key:
CLIGSMOZKDCDRZ-UHFFFAOYSA-N
SMILES:
CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1ccccc1

Properties

Complexity:
450  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
312.159g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
312.373g/mol
Monoisotopic Mass:
312.159g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
69.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4  

Literature

Title Journal
Biophysical mapping of the adenosine A2A receptor. Journal of medicinal chemistry 20110714
A1 receptor mediated adenosinergic regulation of perifornical-lateral hypothalamic area neurons in freely behaving rats. Neuroscience 20100428
Role of adenosine A(1) receptor in the perifornical-lateral hypothalamic area in sleep-wake regulation in rats. Brain research 20091222
Adenosine and adenosine receptors: Newer therapeutic perspective. Indian journal of pharmacology 20090601
DPPX modifies TEA sensitivity of the Kv4 channels in rabbit carotid body chemoreceptor cells. Advances in experimental medicine and biology 20090101
Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience 20080602
Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF? Xenobiotica; the fate of foreign compounds in biological systems 20061201
Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. Journal of medicinal chemistry 20040212
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. Journal of medicinal chemistry 20020523
Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists. Journal of medicinal chemistry 19940513

Related Products

© 2019 Angene International Limited. All rights Reserved.